Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperlipoproteinemia Type II × evolocumab × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Lung Cancer Metastatic 1 Hyperlipoproteinemia Type II 1 Glioma 1 Glioblastoma 1 Coronary Disease 1 Carcinoma, Non-Small-Cell Lung 1 Atherosclerosis 1

Interventions

evolocumab 1 Ezetimibe 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04862260 2024-05-22

Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

CHU de Quebec-Universite Laval

Phase EARLY_PHASE1 Active not recruiting

Gastrointestinal

Hyperlipoproteinemia Type II, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡